Bob Disbrow
Fortuna: 31 M $ al 30/09/2026
Fortuna: 31 M $ al 30/09/2026
Mr. Disbrow joined Haywood in 1999 from First Marathon Securities where he was a director and Branch Manager of the Vancouver office.
A co-founder of First Marathon, he managed the firm's risk capital fund for 10 years and its equity fund for five years.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
Eupraxia Pharmaceuticals, Inc.
Eupraxia Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company focused on the development of delivered, extended-release alternatives to currently approved drugs 5,11 % | 30/09/2025 | 3.368.150 ( 5,11 % ) | 31 M $ | 30/09/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
Haywood Securities, Inc.
Haywood Securities, Inc. Investment Banks/BrokersFinance Provides brokerage services | Ventas Institucionales | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
| Empresas privadas | 1 |
|---|---|
Haywood Securities, Inc.
Haywood Securities, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.